Results 141 to 150 of about 3,923,482 (304)
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng +3 more
wiley +1 more source
Obstructive sleep apnea (OSA) can cause intermittent cerebral hypoxia that may impair brain health. However, widely used clinical indicators such as the Apnea-Hypopnea Index (AHI) and peripheral oxygen saturation (SpO₂) may not accurately capture ...
Chang Hyun Park +4 more
doaj +1 more source
Napping during cognitive behavioural therapy for insomnia: Friends or foes?
Summary Cognitive and Behavioural Therapy for Insomnia (CBT‐I) is the gold standard treatment for chronic insomnia, with one crucial step being the restriction of time spent in bed. This restriction often intensifies early afternoon sleepiness, leading to a natural gateway for a short recuperative nap, which might foster adherence to CBT‐I over time ...
Brice Faraut +5 more
wiley +1 more source
Obstructive sleep apnea (OSA) is a breathing disorder during sleep that can cause obstruction to the flow of breathing with characteristics such as collapse of the upper airway which can cause breathing to stop, either completely (apnea) or partial ...
Adella Bintang Saputri +4 more
doaj +1 more source
Resting state functional thalamic connectivity abnormalities in patients with post-stroke sleep apnoea: a pilot case-control study [PDF]
OBJECTIVE: Sleep apnoea is common after stroke, and has adverse effects on the clinical outcome of affected cases. Its pathophysiological mechanisms are only partially known.
CALISTRI, VALENTINA +9 more
core
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri +8 more
wiley +1 more source
Obstructive Sleep Apnea in Chronic Obstructive Pulmonary Disease: A Prospective Observational Study
Background: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) frequently coexist as overlap syndrome a condition associated with severe nocturnal hypoxemia, increased exacerbations, higher cardiopulmonary morbidity and ...
M. R. Dhanush Kumar +2 more
doaj +1 more source
Effect of Liraglutide on Intermittent Hypoxia‐Induced Metabolic Dysfunction: From Bench to Bedside
ABSTRACT Intermittent hypoxia (IH)‐mediated adipose tissue inflammation with M1 macrophage polarisation plays a key role in the pathogenesis of metabolic diseases in obstructive sleep apnoea (OSA). Effective treatment strategies are so far lacking.
Cliona O'Donnell +11 more
wiley +1 more source
ABSTRACT Obstructive sleep apnea syndrome (OSAS) is characterised by episodic upper airway obstruction that occurs during sleep and is common in children with obesity. The aim of the present study was to analyse the association between baseline anthropometric markers and objective sleep quality measures at follow‐up in school‐aged children with OSAS ...
Catalina Ramírez‐Contreras +2 more
wiley +1 more source

